- Nov 2011 Yakult Establishes Science Foundation in India
- Nov 2011 Approval for a Change in Dosage and Administration of Anticancer Drug,“Elplat®” in Adjuvant Chemotherapy for Colon Cancer
- Nov 2011 LivTech and Yakult Honsha Enter into Option Agreement for LIV-2008,LivTech’s Anti-Cancer Monoclonal Antibodies Program
- Oct 2011 Yakult Issues “Yakult Social & Environmental Report 2011”
- Jul 2011 Yakult Starts Production at Tianjin Plant in China
- Jul 2011 "Supplementary Materials for Financial Statements" updated
- Jul 2011 Yakult Begins Plans to Construct Second Plant in Guangdong Province, China
- Jun 2011 Personnel Change of Directors and Executive Officers
- May 2011 Production and Sale of Yakult LT to Start in Hong Kong
-
May 2011
Sales of Yakult to Begin in Hanoi, Vietnam
-Yakult Vietnam to set up its second operating base in the country- - Apr 2011 Notice of Personnel Change of Representative Director and Introduction of Executive Officer System
- Apr 2011 4SC and Yakult Honsha Announce Exclusive License Agreement for Japan for the Oral HDAC Inhibitor Resminostat
- Mar 2011 Aeterna Zentaris and Yakult Honsha Sign a Development, Commercialization and Licensing Agreement for Lead Oncology Compound, Perifosine, for the Japanese Market
- Jan 2011 Yakult Formulates Long-Term Vision "Yakult Vision 2020"
- Jan 2011 Daily consumption of Lactobacillus casei strain Shirota (LcS) reduces the incidence of upper respiratory tract infections, drinking Yakult daily Yakult trial at Loughborough University, UK